Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms
Clinical trial NCT04196010 · TERMINATED
Trial details
- NCT number
- NCT04196010
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2021-10-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.